Savara (SVRA) Prepaid Assets (2010 - 2026)
Savara (SVRA) reported Prepaid Assets of $6.5 million for Q1 2026, up 4347.26% year-over-year from $146000.0 in Q1 2025, and up 9.79% quarter-over-quarter from $5.9 million in Q4 2025.
Savara (SVRA) Prepaid Assets (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Prepaid Assets data on file, last reported at $6.5 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $6.5 million, up 4347.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.5 million (up 4347.26% YoY), and the FY2025 annual result was $5.9 million, up 4414.5% from the prior year.
- Prepaid Assets advanced to $6.5 million in Q1 2026 per SVRA's latest filing, from $5.9 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $7.0 million in Q3 2024 and troughed at $131000.0 in Q4 2024.
- A 5-year average of $2.2 million and a median of $231000.0 in 2022 frame the typical range for Prepaid Assets.
- On a YoY basis, Prepaid Assets climbed as much as 4414.5% in 2025 and fell as far as 96.81% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $231000.0 in 2022, then slipped by 23.81% to $176000.0 in 2023, then dropped by 25.57% to $131000.0 in 2024, then jumped by 4414.5% to $5.9 million in 2025, then grew by 9.79% to $6.5 million in 2026.
- Business Quant data shows SVRA's Prepaid Assets at $6.5 million in Q1 2026, $5.9 million in Q4 2025, and $3.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.49 Mn |
| Dec 31, 2025 | 5.91 Mn |
| Sep 30, 2025 | 3.81 Mn |
| Jun 30, 2025 | 197,000.00 |
| Mar 31, 2025 | 146,000.00 |
| Dec 31, 2024 | 131,000.00 |
| Sep 30, 2024 | 6.96 Mn |
| Jun 30, 2024 | 6.18 Mn |
| Mar 31, 2024 | 133,000.00 |
| Dec 31, 2023 | 176,000.00 |
| Sep 30, 2023 | 201,000.00 |
| Jun 30, 2023 | 2.72 Mn |
| Mar 31, 2023 | 137,000.00 |
| Dec 31, 2022 | 231,000.00 |
| Sep 30, 2022 | 240,000.00 |
| Jun 30, 2022 | 2.95 Mn |
| Mar 31, 2022 | 187,000.00 |
| Dec 31, 2021 | 3.83 Mn |
| Sep 30, 2021 | 369,000.00 |
| Jun 30, 2021 | 2.82 Mn |